B.C association worries hospice cuts on Vancouver Island could set precedent across the province
Listen to this article Estimated 4 minutes The audio version of this article is generated by text-to-speech, a…
U.S. bishops ban gender-affirming care at Catholic hospitals : NPR
The Rev. Michael J.K. Fuller (from left), Archbishop Timothy Broglio and Archbishop William Lori of Baltimore conduct the…
Rejecting generative AI in healthcare won’t protect patients – it will harm them | US healthcare
Eric Reinhart’s essay raises thoughtful concerns about the risks of generative artificial intelligence (genAI) in healthcare (What we…
2 Strong Healthcare Stock Picks for Dividend Investors
These top dividend payers could enrich a long-term investor’s portfolio. Healthcare tends to be a recession-resistant sector because…
Next-level care earns Pharmasave Val Est Pharmacy top honours.
How Sudbury’s favourite pharmacy is filling the health care gap for local families Picture this: Your child comes…
The Top Startups To Watch From Y Combinator’s Fall 2025 Batch
Origami Blue Unicron getty Since 2005, Y Combinator has backed over 5,000 companies that have a combined valuation…
Poliovirus, SNAP, malaria, MAHA summit: Morning Rounds
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.…
The 18 clinics in Montreal’s west end at risk of closing over Bill 2
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY There with you then. Here with you now. As a critical…
One Twin, 21, Got Colon Cancer, the Other Didn’t. Doctors Don’t Know Why
Brinlee Luster brushed off the exhaustion and stomach cramps as stress. She was finishing college, planning a wedding,…
WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launch
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
Patient complaints on the rise in Ontario: ombudsman
TORONTO — A growing number of people are filing complaints to Ontario’s patient ombudsman office, which says it…
Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…